FIELD: medicine, particularly, cardiosurgery. SUBSTANCE: solution includes potassium chloride, magnesium sulfate, trihydroxymethylaminomethane, distilled water, and additionally contains 15-% solution of mannitol. Administration of solution prevents from brain edema reducing risk of neurological brain complication and does not cause hyperglycemia. EFFECT: higher efficiency. 2 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CARDIOPLEGIC SOLUTION (VERSIONS) | 2014 |
|
RU2574957C1 |
| METHOD FOR CARDIOPLEGIA | 2016 |
|
RU2635523C2 |
| METHOD OF CARDIOPLEGIC ANTEGRADE MYOCARDIAL PROTECTION | 2022 |
|
RU2803867C1 |
| CARDIOPLEGIC "BOKERIA-BOLDYREV" SOLUTION | 2013 |
|
RU2548734C2 |
| METHOD FOR CARDIOPLEGIC ARREST (VERSIONS) | 2015 |
|
RU2571058C1 |
| ASN-BOKERIYA-BOLDYREV CARDIOPLEGIC SOLUTION | 2009 |
|
RU2413502C1 |
| "INFUSOL" CARDIOPLEGIC SOLUTION | 2002 |
|
RU2226093C1 |
| METHOD OF MYOCARDIAL PROTECTION AGAINST ISCHEMIA WITH PHARMACOLOGICAL SOLUTION AND AUTOBLOOD IN DEL NIDO MODIFICATION IN TREATMENT OF ACQUIRED DISEASES OF MITRAL VALVE | 2023 |
|
RU2827770C1 |
| METHOD FOR COMBINED MYOCARDIAL PROTECTION AND A DEVICE FOR PERFORMING BLOOD COLD CARDIOPLEGIA IN HEART OPERATIONS IN NEWBORNS AND INFANTS | 2019 |
|
RU2706017C1 |
| CRYSTALLOID CARDIOPLEGIC SOLUTIONS, CONTAINING DODECAPEPTIDES (VERSIONS) | 2013 |
|
RU2549470C1 |
Authors
Dates
2000-02-27—Published
1997-06-16—Filed